Actively Recruiting
A Stepped Care Model to Deliver CBT-I in Community
Led by Chinese University of Hong Kong · Updated on 2025-07-10
1100
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Insomnia is one of the most common sleep disorders and affects approximately 10 - 40% of the population across different age groups in Hong Kong. Cognitive behavioral therapy for insomnia (CBT-I) is the first line treatment for adult insomnia due to its comparable effect to medication in short term but is more sustainable in the long run. However, only a few sufferers have received CBT-I, due to limited accessibility, lack of trained sleep therapists, time costing and geographical limitations. To increase CBT-I accessibility, different formats of CBT-I have been proposed. Empirical evidence including ours consistently suggested that self-help digital CBT-I is effective in improving sleep while its augmentation with a guided approach could further enhance the treatment gain. Previous evidence has suggested that although self-help CBT-I could lead to positive outcomes, the drop out rate is quite high and maybe less effective for patients with comorbidity or high level of distress. Thus, a stepped-care approach to CBT-I that utilizes online self help and therapist-guided modes of delivery might be a potential way to facilitate efficient dissemination of effective insomnia treatment resources. The effectiveness of the stepped care model will be evaluated in a real world setting using stepped-wedge cluster randomized controlled design. The program will be rolled out to different districts in Hong Kong sequentially in 18 districts over 4 steps with a eqaully spaced time periods.
CONDITIONS
Official Title
A Stepped Care Model to Deliver CBT-I in Community
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chinese adults aged 18-70 years old
- Insomnia Severity Index score of 10 or higher
You will not qualify if you...
- Presence of psychotic disorders such as bipolar disorder and schizophrenia
- Severe depression or suicidal ideation
- Neurodegenerative diseases preventing completion of intervention (e.g., dementia, Parkinson's disease)
- Unable to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Psychiatry, the Chinese University of Hong Kong
Shatin, New Territories, Hong Kong
Actively Recruiting
Research Team
R
Rachel Ngan Yin Chan, PhD
CONTACT
J
Jucheng Yu, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here